| 151 |
REPLReplimune Group, Inc. |
Life Sciences |
0.36 |
$1.1B |
Unlock rating and forecasts |
| 152 |
MNKDMANNKIND CORP |
Life Sciences |
0.62 |
$1.0B |
Unlock rating and forecasts |
| 153 |
IMTXImmatics N.V. |
Life Sciences |
0.35 |
$957M |
Unlock rating and forecasts |
| 154 |
QDELQuidelOrtho Corp |
Life Sciences |
0.05 |
$951M |
Unlock rating and forecasts |
| 155 |
MGTXMeiraGTx Holdings plc |
Life Sciences |
0.30 |
$904M |
Neutral |
-0.39% |
-0.85% |
· |
| 156 |
CGEMCullinan Therapeutics, Inc. |
Life Sciences |
0.40 |
$901M |
Unlock rating and forecasts |
| 157 |
ANROAlto Neuroscience, Inc. |
Life Sciences |
0.21 |
$888M |
Unlock rating and forecasts |
| 158 |
RIGLRIGEL PHARMACEUTICALS INC |
Life Sciences |
0.06 |
$875M |
Neutral |
-0.15% |
-0.26% |
▼ 2 |
| 159 |
CYRXCryoport, Inc. |
Life Sciences |
0.30 |
$865M |
Neutral |
-0.16% |
-0.28% |
▼ 1 |
| 160 |
GLUEMonte Rosa Therapeutics, Inc. |
Life Sciences |
0.15 |
$863M |
Unlock rating and forecasts |
| 161 |
ABUSArbutus Biopharma Corp |
Life Sciences |
0.05 |
$849M |
Unlock rating and forecasts |
| 162 |
AVBPArriVent BioPharma, Inc. |
Life Sciences |
0.18 |
$828M |
Unlock rating and forecasts |
| 163 |
ALMSALUMIS INC. |
Life Sciences |
0.28 |
$817M |
Unlock rating and forecasts |
| 164 |
ARDXARDELYX, INC. |
Life Sciences |
0.38 |
$815M |
Neutral |
-0.28% |
-0.55% |
▼ 2 |
| 165 |
HELPHelus Pharma Inc. |
Life Sciences |
0.18 |
$807M |
Unlock rating and forecasts |
| 166 |
DNAGinkgo Bioworks Holdings, Inc. |
Life Sciences |
0.30 |
$792M |
Unlock rating and forecasts |
| 167 |
GERNGERON CORP |
Life Sciences |
0.11 |
$790M |
Unlock rating and forecasts |
| 168 |
COLLCOLLEGIUM PHARMACEUTICAL, INC |
Life Sciences |
0.63 |
$755M |
Unlock rating and forecasts |
| 169 |
IVAInventiva S.A. |
Life Sciences |
0.25 |
$750M |
Unlock rating and forecasts |
| 170 |
LXRXLEXICON PHARMACEUTICALS, INC. |
Life Sciences |
0.44 |
$734M |
Neutral |
-0.01% |
0.00% |
· |
| 171 |
IMMXImmix Biopharma, Inc. |
Life Sciences |
0.31 |
$720M |
Unlock rating and forecasts |
| 172 |
ACHVACHIEVE LIFE SCIENCES, INC. |
Life Sciences |
0.40 |
$717M |
Unlock rating and forecasts |
| 173 |
FDMT4D Molecular Therapeutics, Inc. |
Life Sciences |
0.22 |
$711M |
Unlock rating and forecasts |
| 174 |
VSTMVerastem, Inc. |
Life Sciences |
0.47 |
$698M |
Unlock rating and forecasts |
| 175 |
SANASana Biotechnology, Inc. |
Life Sciences |
0.28 |
$698M |
Unlock rating and forecasts |
| 176 |
ANNXAnnexon, Inc. |
Life Sciences |
0.31 |
$682M |
Unlock rating and forecasts |
| 177 |
CADLCandel Therapeutics, Inc. |
Life Sciences |
0.41 |
$682M |
Unlock rating and forecasts |
| 178 |
GYREGYRE THERAPEUTICS, INC. |
Life Sciences |
0.05 |
$679M |
Unlock rating and forecasts |
| 179 |
AURAAura Biosciences, Inc. |
Life Sciences |
0.43 |
$657M |
Unlock rating and forecasts |
| 180 |
DSGNDesign Therapeutics, Inc. |
Life Sciences |
0.24 |
$656M |
Unlock rating and forecasts |
| 181 |
AVTXAvalo Therapeutics, Inc. |
Life Sciences |
0.29 |
$644M |
Unlock rating and forecasts |
| 182 |
CLYMClimb Bio, Inc. |
Life Sciences |
0.45 |
$627M |
Unlock rating and forecasts |
| 183 |
IRWDIRONWOOD PHARMACEUTICALS INC |
Life Sciences |
0.22 |
$623M |
Neutral |
-0.39% |
-0.82% |
▲ 1 |
| 184 |
WVEWave Life Sciences, Inc. |
Life Sciences |
0.50 |
$609M |
Unlock rating and forecasts |
| 185 |
ZVRAZEVRA THERAPEUTICS, INC. |
Life Sciences |
0.28 |
$608M |
Unlock rating and forecasts |
| 186 |
PHATPhathom Pharmaceuticals, Inc. |
Life Sciences |
0.17 |
$599M |
Unlock rating and forecasts |
| 187 |
OLMAOlema Pharmaceuticals, Inc. |
Life Sciences |
0.25 |
$595M |
Unlock rating and forecasts |
| 188 |
SLDBSolid Biosciences Inc. |
Life Sciences |
0.13 |
$586M |
Unlock rating and forecasts |
| 189 |
CRMDCorMedix Inc. |
Life Sciences |
0.19 |
$581M |
Neutral |
-0.36% |
-0.74% |
▲ 1 |
| 190 |
PRMEPrime Medicine, Inc. |
Life Sciences |
0.20 |
$568M |
Unlock rating and forecasts |
| 191 |
DBVTDBV Technologies S.A. |
Life Sciences |
0.36 |
$539M |
Neutral |
-0.37% |
-0.76% |
▲ 1 |
| 192 |
STTKShattuck Labs, Inc. |
Life Sciences |
0.35 |
$535M |
Unlock rating and forecasts |
| 193 |
CBIOGYRE THERAPEUTICS, INC. |
Life Sciences |
0.10 |
$534M |
Unlock rating and forecasts |
| 194 |
FTHFaeth Therapeutics, Inc. |
Life Sciences |
0.07 |
$532M |
Neutral |
-0.08% |
-0.12% |
· |
| 195 |
CTMXCytomX Therapeutics, Inc. |
Life Sciences |
0.07 |
$525M |
Unlock rating and forecasts |
| 196 |
DRUGBRIGHT MINDS BIOSCIENCES INC. |
Life Sciences |
0.22 |
$524M |
Unlock rating and forecasts |
| 197 |
ACRSAclaris Therapeutics, Inc. |
Life Sciences |
0.35 |
$514M |
Unlock rating and forecasts |
| 198 |
EOLSEvolus, Inc. |
Life Sciences |
0.50 |
$500M |
Unlock rating and forecasts |
| 199 |
SGMTSagimet Biosciences Inc. |
Life Sciences |
0.35 |
$469M |
Unlock rating and forecasts |
| 200 |
ARVNARVINAS, INC. |
Life Sciences |
0.25 |
$468M |
Unlock rating and forecasts |